With over 25 years of expertise in toxicology, Dr Clive Roper has established himself as a leading figure in developing animal testing replacement technologies. Following his 1994 PhD from Newcastle University, his career spans significant contributions to skin absorption, safety pharmacology, drug metabolism, and various toxicology specialties.

Dr Roper's innovative work has directly replaced animal models in multiple fields, including skin absorption, dermal toxicology, and inhalation studies. In 2021, he founded Roper Toxicology Consulting Limited, focusing on advancing New Approach Methodologies (NAMs).His expertise was further recognized with his 2023 appointment as Vice President of the European Society of Toxicology In Vitro (ESTIV).

As a Fellow of the RoyalSociety of Biology and a European Registered Toxicologist, Dr Roper maintains membership in several prestigious professional organizations. His influence extends to board positions with organizations committed to replacing, refining and reducing animal testing, including the UK NC3Rs, US 3Rs Collaborative, and PeptiMatrix, which develops chemically defined animal-free media products.

‍

Dr Roper brings valuable insights on developing animal-free testing methodologies that meet scientific standards, regulatory requirements, and strategic business objectives in today's evolving research landscape.

‍